TAC-话题@MedSci

#TAC#

115篇内容 | 2836人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2033715, encodeId=cb552033e15f1, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=病例：TACE+TAI+免疫+靶向，术后肝内多病灶复发肝癌患者疗效竟然达CR, objectType=article, longId=182272, objectId=74991822e285, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74991822e285, replyNumber=0, likeNumber=60, createdTime=2020-04-23, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74991822e285, moduleTitle=病例：TACE+TAI+免疫+靶向，术后肝内多病灶复发肝癌患者疗效竟然达CR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74991822e285)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033718, encodeId=a6d12033e18e8, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Incyte宣布JAK1抑制剂Itacitinib在移植物抗宿主病患者中的3期研究结果, objectType=article, longId=185644, objectId=baa51856448b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=baa51856448b, replyNumber=0, likeNumber=62, createdTime=2020-03-26, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=baa51856448b, moduleTitle=Incyte宣布JAK1抑制剂Itacitinib在移植物抗宿主病患者中的3期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=baa51856448b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033717, encodeId=c3712033e1703, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=滕皋军教授：肝癌综合治疗新时代--TACE与系统治疗“强强联合”, objectType=article, longId=184914, objectId=d61c1849143f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d61c1849143f, replyNumber=0, likeNumber=64, createdTime=2020-01-11, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d61c1849143f, moduleTitle=滕皋军教授：肝癌综合治疗新时代--TACE与系统治疗“强强联合”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d61c1849143f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033712, encodeId=edcd2033e126c, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Arvinas宣布启动1期临床研究，评估其靶向雌激素受体的PROTAC蛋白质降解剂ARV-471治疗乳腺癌的活性, objectType=article, longId=178296, objectId=d3011e8296df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3011e8296df, replyNumber=0, likeNumber=68, createdTime=2019-09-11, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3011e8296df, moduleTitle=Arvinas宣布启动1期临床研究，评估其靶向雌激素受体的PROTAC蛋白质降解剂ARV-471治疗乳腺癌的活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3011e8296df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033720, encodeId=d5b62033e209b, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长, objectType=article, longId=187870, objectId=4a7018e87076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a7018e87076, replyNumber=0, likeNumber=68, createdTime=2020-10-09, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a7018e87076, moduleTitle=Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a7018e87076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033704, encodeId=a50c2033e0495, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=邓迪大学与勃林格殷格翰合作通过opnMe.com免费提供PROTAC化合物, objectType=article, longId=157794, objectId=0a5a15e79411, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a5a15e79411, replyNumber=0, likeNumber=82, createdTime=2019-04-30, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a5a15e79411, moduleTitle=邓迪大学与勃林格殷格翰合作通过opnMe.com免费提供PROTAC化合物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a5a15e79411)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033716, encodeId=17272033e16b4, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Dent Mater J：GuttaCore Pink, Thermafil和热垂直加压牙胶的再治疗, objectType=article, longId=183200, objectId=22981832003d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22981832003d, replyNumber=0, likeNumber=94, createdTime=2020-03-18, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22981832003d, moduleTitle=Dent Mater J：GuttaCore Pink, Thermafil和热垂直加压牙胶的再治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22981832003d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033707, encodeId=e28a2033e078a, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=2019 NTAC/CDC建议：结核病的筛查、检测和治疗, objectType=article, longId=166659, objectId=820c16665914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=820c16665914, replyNumber=0, likeNumber=27, createdTime=2019-10-04, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=820c16665914, moduleTitle=2019 NTAC/CDC建议：结核病的筛查、检测和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=820c16665914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033710, encodeId=88b62033e1072, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=J Endod：Prostacyclin Analog通过MMP-9相关通路促进人牙髓细胞的迁移, objectType=article, longId=167892, objectId=c48f16e8922f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c48f16e8922f, replyNumber=0, likeNumber=62, createdTime=2019-11-01, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c48f16e8922f, moduleTitle=J Endod：Prostacyclin Analog通过MMP-9相关通路促进人牙髓细胞的迁移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c48f16e8922f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033708, encodeId=062c2033e0846, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=【2019 ASCO】聚焦中期肝细胞癌综合治疗，TACE的选择和优化, objectType=article, longId=167646, objectId=9fd616e64663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fd616e64663, replyNumber=0, likeNumber=30, createdTime=2019-07-24, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fd616e64663, moduleTitle=【2019 ASCO】聚焦中期肝细胞癌综合治疗，TACE的选择和优化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fd616e64663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033706, encodeId=e7762033e0629, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Nature:针对前列腺癌的PROTACs已进入临床试验！或将开启蛋白靶向降解治疗癌症新篇章！, objectType=article, longId=163067, objectId=e00716306e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e00716306e43, replyNumber=0, likeNumber=64, createdTime=2019-04-02, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e00716306e43, moduleTitle=Nature:针对前列腺癌的PROTACs已进入临床试验！或将开启蛋白靶向降解治疗癌症新篇章！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e00716306e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033709, encodeId=be3d2033e0951, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=ASCO2019|TACE + RFA联用治疗中期（BCLC B期）肝癌改善患者生存期, objectType=article, longId=167670, objectId=f89f16e6704f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f89f16e6704f, replyNumber=0, likeNumber=75, createdTime=2019-08-30, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f89f16e6704f, moduleTitle=ASCO2019|TACE + RFA联用治疗中期（BCLC B期）肝癌改善患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f89f16e6704f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033711, encodeId=b2df2033e11bf, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=聚焦中期肝细胞癌综合治疗，TACE的选择和优化, objectType=article, longId=167922, objectId=597916e92253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597916e92253, replyNumber=0, likeNumber=67, createdTime=2020-01-31, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597916e92253, moduleTitle=聚焦中期肝细胞癌综合治疗，TACE的选择和优化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597916e92253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033705, encodeId=44682033e057a, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=中国肝细胞癌经动脉化疗栓塞治疗（TACE）临床实践指南, objectType=article, longId=158247, objectId=bb4b15824eb7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb4b15824eb7, replyNumber=0, likeNumber=30, createdTime=2019-11-23, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb4b15824eb7, moduleTitle=中国肝细胞癌经动脉化疗栓塞治疗（TACE）临床实践指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb4b15824eb7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033702, encodeId=c5af2033e0235, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=JAMA Oncol：大血管侵犯的晚期肝细胞癌：TACE+RT vs索拉菲尼, objectType=article, longId=144713, objectId=5e6f144e13a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e6f144e13a6, replyNumber=0, likeNumber=70, createdTime=2019-06-08, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e6f144e13a6, moduleTitle=JAMA Oncol：大血管侵犯的晚期肝细胞癌：TACE+RT vs索拉菲尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e6f144e13a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033701, encodeId=bbf72033e01a0, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Radiology：肝癌多柔比星洗脱微球（DEB）TACE治疗后移植肝还好吗？, objectType=article, longId=138970, objectId=62001389e0e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62001389e0e2, replyNumber=0, likeNumber=52, createdTime=2019-04-01, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62001389e0e2, moduleTitle=Radiology：肝癌多柔比星洗脱微球（DEB）TACE治疗后移植肝还好吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62001389e0e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033698, encodeId=5d9f20336989c, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=JAMA Oncol：传统治疗方式的“逆袭” :TACE+放疗治疗晚期HCC患者, objectType=article, longId=134331, objectId=97871343311c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97871343311c, replyNumber=0, likeNumber=67, createdTime=2018-08-02, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97871343311c, moduleTitle=JAMA Oncol：传统治疗方式的“逆袭” :TACE+放疗治疗晚期HCC患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97871343311c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033703, encodeId=31342033e035e, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=2018 台湾多学科建议：应用DEBDOX-TACE治疗肝细胞癌, objectType=article, longId=155192, objectId=d00b1551920e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d00b1551920e, replyNumber=0, likeNumber=29, createdTime=2019-06-20, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d00b1551920e, moduleTitle=2018 台湾多学科建议：应用DEBDOX-TACE治疗肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d00b1551920e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033697, encodeId=cf3f203369e07, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Hepatology：预防肝癌患者TACE引发的不良事件不妨试试这个方案, objectType=article, longId=133165, objectId=63b7133165fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63b7133165fc, replyNumber=0, likeNumber=52, createdTime=2018-08-21, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63b7133165fc, moduleTitle=Hepatology：预防肝癌患者TACE引发的不良事件不妨试试这个方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63b7133165fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033700, encodeId=b7062033e00ef, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=FDA批准辉瑞的生物仿制药Retacrit, objectType=article, longId=138358, objectId=39b313835837, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39b313835837, replyNumber=0, likeNumber=65, createdTime=2018-08-03, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39b313835837, moduleTitle=FDA批准辉瑞的生物仿制药Retacrit, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39b313835837)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TAC

2020-05-29

grace5700 (审核中...)

前往app查看评论内容

#TAC#

病例：TACE+TAI+免疫+靶向，术后肝内多病灶复发肝癌患者疗效竟然达CR

2020-04-23

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Incyte宣布JAK1抑制剂Itacitinib在移植物抗宿主病患者中的3期研究结果

2020-03-26

grace5700 (审核中...)

前往app查看评论内容

#TAC#

滕皋军教授：肝癌综合治疗新时代--TACE与系统治疗“强强联合”

2020-01-11

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Arvinas宣布启动1期临床研究，评估其靶向雌激素受体的PROTAC蛋白质降解剂ARV-471治疗乳腺癌的活性

2019-09-11

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长

2020-10-09

grace5700 (审核中...)

前往app查看评论内容

#TAC#

邓迪大学与勃林格殷格翰合作通过opnMe.com免费提供PROTAC化合物

2019-04-30

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Dent Mater J：GuttaCore Pink, Thermafil和热垂直加压牙胶的再治疗

2020-03-18

grace5700 (审核中...)

前往app查看评论内容

#TAC#

2019 NTAC/CDC建议：结核病的筛查、检测和治疗

2019-10-04

grace5700 (审核中...)

前往app查看评论内容

#TAC#

J Endod：Prostacyclin Analog通过MMP-9相关通路促进人牙髓细胞的迁移

2019-11-01

grace5700 (审核中...)

前往app查看评论内容

#TAC#

【2019 ASCO】聚焦中期肝细胞癌综合治疗，TACE的选择和优化

2019-07-24

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Nature:针对前列腺癌的PROTACs已进入临床试验！或将开启蛋白靶向降解治疗癌症新篇章！

2019-04-02

grace5700 (审核中...)

前往app查看评论内容

#TAC#

ASCO2019|TACE + RFA联用治疗中期（BCLC B期）肝癌改善患者生存期

2019-08-30

grace5700 (审核中...)

前往app查看评论内容

#TAC#

聚焦中期肝细胞癌综合治疗，TACE的选择和优化

2020-01-31

grace5700 (审核中...)

前往app查看评论内容

#TAC#

中国肝细胞癌经动脉化疗栓塞治疗（TACE）临床实践指南

2019-11-23

grace5700 (审核中...)

前往app查看评论内容

#TAC#

JAMA Oncol：大血管侵犯的晚期肝细胞癌：TACE+RT vs索拉菲尼

2019-06-08

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Radiology：肝癌多柔比星洗脱微球（DEB）TACE治疗后移植肝还好吗？

2019-04-01

grace5700 (审核中...)

前往app查看评论内容

#TAC#

JAMA Oncol：传统治疗方式的“逆袭” :TACE+放疗治疗晚期HCC患者

2018-08-02

grace5700 (审核中...)

前往app查看评论内容

#TAC#

2018 台湾多学科建议：应用DEBDOX-TACE治疗肝细胞癌

2019-06-20

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Hepatology：预防肝癌患者TACE引发的不良事件不妨试试这个方案

2018-08-21

grace5700 (审核中...)

前往app查看评论内容

#TAC#

FDA批准辉瑞的生物仿制药Retacrit

2018-08-03

科室
- - 订阅+
  - 更多科室
工具
服务